Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy
慢性淋巴细胞白血病(CLL)患者停用维奈托克后治疗效果评估显示,BTK抑制剂是一种有效策略
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-19-3815
Mato, Anthony R; Roeker, Lindsey E; Jacobs, Ryan; Hill, Brian T; Lamanna, Nicole; Brander, Danielle; Shadman, Mazyar; Ujjani, Chaitra S; Yazdy, Maryam Sarraf; Perini, Guilherme Fleury; Pinilla-Ibarz, Javier A; Barrientos, Jacqueline; Skarbnik, Alan P; Torka, Pallawi; Pu, Jeffrey J; Pagel, John M; Gohil, Satyen; Fakhri, Bita; Choi, Michael; Coombs, Catherine C; Rhodes, Joanna; Barr, Paul M; Portell, Craig A; Parry, Helen; Garcia, Christine A; Whitaker, Kate J; Winter, Allison M; Sitlinger, Andrea; Khajavian, Sirin; Grajales-Cruz, Ariel F; Isaac, Krista M; Shah, Pratik; Akhtar, Othman S; Pocock, Rachael; Lam, Kentson; Voorhees, Timothy J; Schuster, Stephen J; Rodgers, Thomas D; Fox, Christopher P; Martinez-Calle, Nicolas; Munir, Talha; Bhavsar, Erica B; Bailey, Neil; Lee, Jason C; Weissbrot, Hanna B; Nabhan, Chadi; Goodfriend, Julie M; King, Amber C; Zelenetz, Andrew D; Dorsey, Colleen; Bigelow, Kayla; Cheson, Bruce D; Allan, John N; Eyre, Toby A